Lombard Odier Asset Management (USA)’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Hold |
0
| – | – | – | 340 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 351 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 241 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 254 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 248 |
|
2019
Q1 | – | Sell |
-1,025
| Closed | -$76K | – | 272 |
|
2018
Q4 | $76K | Sell |
1,025
-463
| -31% | -$34.3K | 0.01% | 160 |
|
2018
Q3 | $213K | Sell |
1,488
-512
| -26% | -$73.3K | 0.02% | 163 |
|
2018
Q2 | $286K | Hold |
2,000
| – | – | 0.02% | 169 |
|
2018
Q1 | $353K | Buy |
+2,000
| New | +$353K | 0.03% | 141 |
|
2017
Q4 | – | Sell |
-2,000
| Closed | -$1.15M | – | 210 |
|
2017
Q3 | $1.15M | Hold |
2,000
| – | – | 0.08% | 113 |
|
2017
Q2 | $1.97M | Buy |
2,000
+107
| +6% | +$106K | 0.16% | 97 |
|
2017
Q1 | $2.52M | Buy |
1,893
+773
| +69% | +$1.03M | 0.24% | 87 |
|
2016
Q4 | $612K | Sell |
1,120
-17
| -1% | -$9.29K | 0.08% | 112 |
|
2016
Q3 | $615K | Buy |
1,137
+455
| +67% | +$246K | 0.06% | 182 |
|
2016
Q2 | $630K | Hold |
682
| – | – | 0.08% | 150 |
|
2016
Q1 | $1.1M | Sell |
682
-27
| -4% | -$43.5K | 0.15% | 126 |
|
2015
Q4 | $1.11M | Buy |
709
+29
| +4% | +$45.2K | 0.11% | 132 |
|
2015
Q3 | $1.89M | Buy |
680
+90
| +15% | +$250K | 0.16% | 140 |
|
2015
Q2 | $3M | Buy |
590
+77
| +15% | +$391K | 0.21% | 128 |
|
2015
Q1 | $3.63M | Buy |
+513
| New | +$3.63M | 0.29% | 99 |
|